Literature DB >> 18189227

Heterogeneity in preferences for smoking cessation.

Robert W Paterson1, Kevin J Boyle, Christopher F Parmeter, James E Neumann, Paul De Civita.   

Abstract

Promoting cessation is a cornerstone of tobacco control efforts by public-health agencies. Economic information to support cessation programs has generally emphasized cost-effectiveness or the impact of cigarette pricing and smoking restrictions on quit rates. In contrast, this study provides empirical estimates of smoker preferences for increased efficacy and other attributes of smoking cessation therapies (SCTs). Choice data were collected through a national survey of Canadian smokers. We find systematic preference heterogeneity for therapy types and SCT attributes between light and heavy smokers, as well as random heterogeneity using random parameters logit models. Preference heterogeneity is greatest between length of use and types of SCTs. We estimate that light smokers would be willing to pay nearly $500 ($CAN) to increase success rates to 40% with the comparable figure for heavy smokers being near $300 ($CAN). Results from this study can be used to inform research and development for smoking cessation products and programs and suggest important areas of future inquiry regarding heterogeneity of smoker preferences and preferences for other health programs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18189227     DOI: 10.1002/hec.1336

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  8 in total

1.  Development of a Discrete Choice Experiment (DCE) Questionnaire to Understand Veterans' Preferences for Tobacco Treatment in Primary Care.

Authors:  David A Katz; Kenda R Stewart; Monica Paez; Mark W Vander Weg; Kathleen M Grant; Christine Hamlin; Gary Gaeth
Journal:  Patient       Date:  2018-12       Impact factor: 3.883

2.  Assessing preferences for improved smoking cessation medications: a discrete choice experiment.

Authors:  Joachim Marti
Journal:  Eur J Health Econ       Date:  2011-06-26

3.  Eliciting preferences to inform patient-centred policies: the case of psoriasis.

Authors:  Aleksandra Torbica; Giovanni Fattore; Fabio Ayala
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

4.  A Cross-sectional Examination of What Smokers Perceive to be Important and Their Willingness to Pay for Tobacco Cessation Medications.

Authors:  Shanta R Dube; Michael F Pesko; Xin Xu
Journal:  J Public Health Manag Pract       Date:  2016 Jan-Feb

Review 5.  Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review.

Authors:  Kabindra Regmi; Dinesh Kaphle; Sabina Timilsina; Nik Annie Afiqah Tuha
Journal:  Pharmacoecon Open       Date:  2018-03

6.  Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Frank T Leone; Yuqing Zhang; Sarah Evers-Casey; A Eden Evins; Michelle N Eakin; Joelle Fathi; Kathleen Fennig; Patricia Folan; Panagis Galiatsatos; Hyma Gogineni; Stephen Kantrow; Hasmeena Kathuria; Thomas Lamphere; Enid Neptune; Manuel C Pacheco; Smita Pakhale; David Prezant; David P L Sachs; Benjamin Toll; Dona Upson; Dan Xiao; Luciane Cruz-Lopes; Izabela Fulone; Rachael L Murray; Kelly K O'Brien; Sureka Pavalagantharajah; Stephanie Ross; Yuan Zhang; Meng Zhu; Harold J Farber
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

7.  Methods Used in Smoking Cessation and Reduction Attempts: Findings from Help-Seeking Smokers.

Authors:  Marianne Lund; Elisabeth Kvaavik
Journal:  J Smok Cessat       Date:  2021-03-09

8.  Smaller Cigarette Pack as a Commitment to Smoke Less? Insights from Behavioral Economics.

Authors:  Joachim Marti; Jody Sindelar
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.